Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CDH2 | CCLE | pan-cancer | AAC | -0.15 | 0.008 |
mRNA | TULP3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | TXNRD1 | CCLE | pan-cancer | AAC | -0.14 | 0.008 |
mRNA | KRT33B | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
mRNA | NPTN | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
mRNA | SUCLG1 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
mRNA | PTGFRN | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
mRNA | FBXO43 | CCLE | pan-cancer | AAC | -0.14 | 0.008 |
mRNA | GPT2 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
mRNA | KCNJ4 | FIMM | pan-cancer | AAC | -0.45 | 0.008 |